Airway Pressure During Nasal High Flow and CPAP in Neonates
Primary Purpose
Respiratory Insufficiency
Status
Completed
Phase
Not Applicable
Locations
Armenia
Study Type
Interventional
Intervention
NHF small cannula
NHF big cannula
CPAP
Sponsored by
About this trial
This is an interventional basic science trial for Respiratory Insufficiency focused on measuring Nasal High Flow, CPAP, airway pressure, newborn
Eligibility Criteria
Inclusion Criteria:
- Healthy term newborns
Exclusion Criteria:
- Newborns with any medical problems after birth
- Absent of parents consents
Sites / Locations
- Neonatal Intensive Care Unit, Research Centre of Maternal and Child Health
- RCMCHP
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Experimental
Experimental
Experimental
No Intervention
Arm Label
NHF small cannula
NHF big cannula
Mask CPAP
no intervention
Arm Description
NHF 8 L/min (Airvo2) , Smaller cannula (neonatal, yellow)
NHF 8 L/min (Airvo2) , Bigger cannula (neonatal, purple)
CPAP 5cm H2O
control
Outcomes
Primary Outcome Measures
Upper airway pressure generated by NHF compared to CPAP
Pressure in upper airways
Secondary Outcome Measures
Full Information
NCT ID
NCT02632799
First Posted
September 10, 2015
Last Updated
October 29, 2019
Sponsor
Research Center of Maternal and Child Health Protection, Armenia
Collaborators
Fisher and Paykel Healthcare
1. Study Identification
Unique Protocol Identification Number
NCT02632799
Brief Title
Airway Pressure During Nasal High Flow and CPAP in Neonates
Official Title
Airway Pressure During Nasal High Flow and CPAP in Neonates
Study Type
Interventional
2. Study Status
Record Verification Date
October 2019
Overall Recruitment Status
Completed
Study Start Date
January 2015 (undefined)
Primary Completion Date
August 2015 (Actual)
Study Completion Date
August 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Research Center of Maternal and Child Health Protection, Armenia
Collaborators
Fisher and Paykel Healthcare
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Nasal High Flow (NHF) and CPAP are established forms of respiratory support in neonates and often produce similar clinical outcomes. The aim of the study was to investigate airway pressure during NHF and CPAP in neonates.
Detailed Description
Methods: A physiological study which measured pressure intra-nasally with micro (750 µm) pressure probes (Millar, USA) in 10 (5M / 5F) healthy newborns with mean gestation age 37.18 (SD 1.29) wk and mean birth weight of 2414 (SD 503.13) g. NHF was applied at 8 L/min (AIRVO 2) through smaller (OPT 314) and larger (OPT 316) Optiflow nasal cannula; CPAP 5 cmH20 was produced by a Bubble CPAP system and nasal mask interface at constant flow 8 L/min (Fisher & Paykel Healthcare, NZ). Values are expressed in cmH20 as means and standard deviations (SD).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Respiratory Insufficiency
Keywords
Nasal High Flow, CPAP, airway pressure, newborn
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
10 (Actual)
8. Arms, Groups, and Interventions
Arm Title
NHF small cannula
Arm Type
Experimental
Arm Description
NHF 8 L/min (Airvo2) , Smaller cannula (neonatal, yellow)
Arm Title
NHF big cannula
Arm Type
Experimental
Arm Description
NHF 8 L/min (Airvo2) , Bigger cannula (neonatal, purple)
Arm Title
Mask CPAP
Arm Type
Experimental
Arm Description
CPAP 5cm H2O
Arm Title
no intervention
Arm Type
No Intervention
Arm Description
control
Intervention Type
Device
Intervention Name(s)
NHF small cannula
Other Intervention Name(s)
Optiflow, HFNC
Intervention Description
NHF 8 l/min by Airvo 2 by small cannula
Intervention Type
Device
Intervention Name(s)
NHF big cannula
Other Intervention Name(s)
Optiflow, HFNC
Intervention Description
NHF 8 l/min by Airvo 2 by large cannula
Intervention Type
Device
Intervention Name(s)
CPAP
Intervention Description
Nsal CPAP 5cm H2o by face mask
Primary Outcome Measure Information:
Title
Upper airway pressure generated by NHF compared to CPAP
Description
Pressure in upper airways
Time Frame
Up to 1 hour
10. Eligibility
Sex
All
Minimum Age & Unit of Time
1 Day
Maximum Age & Unit of Time
3 Days
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Healthy term newborns
Exclusion Criteria:
Newborns with any medical problems after birth
Absent of parents consents
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pavel Mazmanyan, MD PhD
Organizational Affiliation
Research Center of Maternal and Child Health Protection, Armenia
Official's Role
Principal Investigator
Facility Information:
Facility Name
Neonatal Intensive Care Unit, Research Centre of Maternal and Child Health
City
Yerevan
ZIP/Postal Code
0002
Country
Armenia
Facility Name
RCMCHP
City
Yerevan
ZIP/Postal Code
0002
Country
Armenia
12. IPD Sharing Statement
Learn more about this trial
Airway Pressure During Nasal High Flow and CPAP in Neonates
We'll reach out to this number within 24 hrs